Opentrons

US-based Opentrons has revolutionized the lower-end of the market, deploying thousands of affordable, Python-driven pipetting robots to labs that previously relied on manual labor.

Country
United States
Commercial Open Source
Coverage
CNEUUS
automation-robotics
Regulatorsfdaemanmpa

Verifiable facts

FactValueSource
Funding$200M Series C funding round led by SoftBank (total funding reported between $232.8M and $270.95M) (2021-09-23)getlatka.com · opentrons.com
CapacityMore than 10,000 robotic systems deployed globallyopentrons.com
CertificationCE, UL, FCC, ISO 9001 (Not certified for IVD or GMP)opentrons.com
Regulatory approvalCompliance Ready Software (Opentrons CRS) is aligned with U.S. FDA Title 21 CFR Part 11 for non-GMP regulated environmentsopentrons.com · therobotreport.com
Production siteShenzhen, China (Maqueling Industrial Science and Technology Park)panjiva.com · highperformr.ai · importgenius.com
Headcount208 to 328 employees medium confidencegetlatka.com
Revenue$45M annual revenue (estimated ARR) (2024-12-31)getlatka.com

Independent sources: getlatka.com · highperformr.ai · importgenius.com · panjiva.com · therobotreport.com

Technologies
NameClusterRisk
Lab automation & liquid handlingautomation-roboticsLow
Lab automation & wet-lab roboticsautomation-roboticsLow

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.